N.V. Rajeshkumar - Concepedia

Author

N.V. Rajeshkumar

Johns Hopkins University

Also Known As

N V Rajeshkumar, N. RajeshKumar, N. Rajeshkumar, N. V. Rajeshkumar, N.V Rajeshkumar, N.V. Rajeshkumar, NV Rajeshkumar

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine The University of Texas MD Anderson Cancer Center Universidad San Pablo CEU

About

N.V. Rajeshkumar is an author at Johns Hopkins University specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	596
2	Cell Biology	4	4	391
3	Engineering	1	1	16
4	Health Sciences	1	1	83
5	Biochemistry	1	1	156

N.V. Rajeshkumar

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Journal of Clinical Oncology	2011	1K
Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations Annan Yang, N.V. Rajeshkumar, Xiaoxu Wang, Cancer Discovery	2014	474
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma Zeshaan A. Rasheed, Jie Yang, Qiuju Wang, JNCI Journal of the National Cancer Institute	2010	428
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer Manuel Hidalgo, Elizabeth Bruckheimer, N.V. Rajeshkumar, Molecular Cancer Therapeutics	2011	400
MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts N.V. Rajeshkumar, Elizabeth De Oliveira, Niki A. Ottenhof, Clinical Cancer Research	2011	274
Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer Ignacio Garrido‐Laguna, Maria Uson, N.V. Rajeshkumar, Clinical Cancer Research	2011	250
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: <i>PALB2</i> Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer Maria Cristina Villarroel, N.V. Rajeshkumar, Ignacio Garrido‐Laguna, Molecular Cancer Therapeutics	2010	245
Characterizing DNA methylation patterns in pancreatic cancer genome Aik Choon Tan, Antonio Jimeno, Steven H. Lin, Molecular Oncology	2009	160
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma Ana De Jesus‐Acosta, Elizabeth A. Sugar, Peter J. O’Dwyer, British Journal of Cancer	2019	158
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function N.V. Rajeshkumar, Prasanta Dutta, Shinichi Yabuuchi, Cancer Research Chemoprevention StrategyPathologyMetabolic RemodelingWarburg EffectCancer Biology	2015	156

Page 1